巨星醫療控股(02393.HK):2020年歸屬於母公司擁有人虧損5.9億元 4月8日起復牌
格隆匯 4 月 7日丨巨星醫療控股(02393.HK)發佈公吿,收益同比減少約16.2%至2020年約人民幣41.069億元,2020年的每股虧損為人民幣25.0分。截至2020年12月31日止六個月的收益為人民幣25.046億元,較截至2020年6月30日止六個月的人民幣16.023億元增加56.3%。
2020年歸屬於母公司擁有人的虧損約為人民幣5.905億元,相比2019年歸屬於母公司擁有人的溢利約人民幣2.027億元減少約人民幣7.932億元。2020年,商譽減值虧損為人民幣4.475億元(2019年:人民幣3990萬元),其他無形資產減值虧損為人民幣3.429億元(2019年:無),減值虧損總額為人民幣7.904億元。
應公司要求,公司股份及優先票據由2021年4月1日上午九時正起暫停在聯交所買賣,以待發表本公佈。公司已向聯交所申請由4月8日上午九時正起恢復公司股份及優先票據買賣。公司股份及優先票據將會恢復買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.